Adeno-associated virus effectively mediates conditional gene modification in the brain

被引:156
作者
Kaspar, BK
Vissel, B
Bengoechea, T
Crone, S
Randolph-Moore, L
Muller, R
Brandon, EP
Schaffer, D
Verma, IM
Lee, KF
Heinemann, SF
Gage, FH
机构
[1] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA
[2] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA
[3] Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA
关键词
gene transfer; Cre recombinase; transgenic mouse; loxP; ROSA26;
D O I
10.1073/pnas.042678699
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Cre/loxP system is increasingly showing promise for investigating genes involved in neural function. Here, we demonstrate that in vivo modification of genes in the mouse brain can be accomplished in a spatial- and temporal-specific manner by targeted delivery of an adeno-associated virus (AAV) encoding a green fluorescent protein/Cre recombinase (GFP/Cre) fusion protein. By using a reporter mouse, in which Cre recombinase activates beta-galactosidase expression, we demonstrate long-term recombination of neurons in the hippocampus, striatum, and septum as early as 7 days after stereotaxic injection of virus. Recombined cells were observed for at least 6 months postinjection without evidence of cell loss or neural damage. AAV-mediated delivery of GFP/Cre provides a valuable approach to alter the mouse genome, as AAV delivers genes efficiently to neurons with low toxicity. This approach will greatly facilitate the study of genetic modifications in the mouse brain.
引用
收藏
页码:2320 / 2325
页数:6
相关论文
共 39 条
[11]   Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis [J].
Fisher, KJ ;
Gao, GP ;
Weitzman, MD ;
DeMatteo, R ;
Burda, JF ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1996, 70 (01) :520-532
[12]   CELLS ENGINEERED TO PRODUCE ACETYLCHOLINE - THERAPEUTIC POTENTIAL FOR ALZHEIMERS-DISEASE [J].
FISHER, LJ ;
RAYMON, HK ;
GAGE, FH .
ALZHEIMERS DISEASE: AMYLOID PRECUSOR PROTEINS, SIGNAL TRANSDUCTION, AND NEURONAL TRANSPLANTATION, 1993, 695 :278-284
[13]   CHARACTERISTICS OF A HUMAN CELL LINE TRANSFORMED BY DNA FROM HUMAN ADENOVIRUS TYPE-5 [J].
GRAHAM, FL ;
SMILEY, J ;
RUSSELL, WC ;
NAIRN, R .
JOURNAL OF GENERAL VIROLOGY, 1977, 36 (JUL) :59-72
[14]   LONG-TERM GENE-EXPRESSION AND PHENOTYPIC CORRECTION USING ADENOASSOCIATED VIRUS VECTORS IN THE MAMMALIAN BRAIN [J].
KAPLITT, MG ;
LEONE, P ;
SAMULSKI, RJ ;
XIAO, X ;
PFAFF, DW ;
OMALLEY, KL ;
DURING, MJ .
NATURE GENETICS, 1994, 8 (02) :148-154
[15]   Targeted retrograde gene delivery for neuronal protection [J].
Kaspar, BK ;
Erickson, D ;
Schaffer, D ;
Hinh, L ;
Gage, FH ;
Peterson, DA .
MOLECULAR THERAPY, 2002, 5 (01) :50-56
[16]   INDUCIBLE GENE TARGETING IN MICE [J].
KUHN, R ;
SCHWENK, F ;
AGUET, M ;
RAJEWSKY, K .
SCIENCE, 1995, 269 (5229) :1427-1429
[17]   Adeno-associated virus-mediated gene transfer to the brain: Duration and modulation of expression [J].
Lo, WD ;
Qu, G ;
Sferra, TJ ;
Clark, R ;
Chen, RJ ;
Johnson, PR .
HUMAN GENE THERAPY, 1999, 10 (02) :201-213
[18]   Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells [J].
Loonstra, A ;
Vooijs, M ;
Beverloo, HB ;
Al Allak, B ;
van Drunen, E ;
Kanaar, R ;
Berns, A ;
Jonkers, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9209-9214
[19]   Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector [J].
McCown, TJ ;
Xiao, X ;
Li, J ;
Breese, GR ;
Samulski, RJ .
BRAIN RESEARCH, 1996, 713 (1-2) :99-107
[20]  
PETERSON DA, 1994, J NEUROSCI, V14, P6872